Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Belgium Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20081
20103
20116
20121
20131
20142
20152
20165
20172
20184
20192
20204
20217
20221
20233
20246
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated11
Recruiting8
Active, not recruiting6
Not yet recruiting2
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Pfizer6
Universitaire Ziekenhuizen KU Leuven6
Janssen Research & Development, LLC5
Imelda GI Clinical Research Center3
GlaxoSmithKline2
KU Leuven2
OSE Immunotherapeutics2
Spyre Therapeutics, Inc.2
University Medical Center Groningen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases61
Colitis, Ulcerative29
Crohn Disease26
Colitis7
Gastrointestinal Diseases5
Intestinal Diseases3
Colonic Diseases2
Digestive System Diseases2
Irritable Bowel Syndrome2
Abdominal Pain1

Trials

Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.